Working… Menu
Trial record 1 of 1 for:    NCT03312634
Previous Study | Return to List | Next Study

An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva. (MOVE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03312634
Recruitment Status : Active, not recruiting
First Posted : October 18, 2017
Last Update Posted : August 2, 2021
Information provided by (Responsible Party):
Ipsen ( Clementia Pharmaceuticals Inc. )

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : January 24, 2020
Estimated Study Completion Date : November 2022
Certification/Extension First Submitted : January 20, 2021